FindTrial
Sign In

Postoperative pain after cesarean section :efficacy of S-ketamine at antihyperalgesic doses. - ND

Postoperative pain after cesarean section :efficacy of S-ketamine at antihyperalgesic doses. - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005635-25-IT
Enrollment
Unknown
Registered
2007-06-04
Start date
2006-11-15
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after cesarean section MedDRA version: 6.1 Level: PT Classification code 10006924

Interventions

Trade Name: ketanest-s Pharmaceutical Form: Solution for infusion INN or Proposed INN: Ketamine Concentration unit: mg milligram(s) Concentration type: equal Concentration number: .5- Pharmaceutical f

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: parturients undergoing elective caesarean section ,aged 18-40, ASA I-II. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - patients ASA III-IV (significant co-existing maternal cardiovascular, respiratory ,neurologic, endocrine, metabolic and psychiatric disease ) - pathologic pregnancy - week gestation < 37 - absolute and relative contraindications to spinal anaesthesia - patient refusal

Design outcomes

Primary

MeasureTime frame
Main Objective: Difference in morphine consumption between groups. Difference in pain threshold between groups at prefixed times.;Secondary Objective: Comparison between groups about: lenght of spinal analgesia(time to first request of morphine). maternal side effects;Primary end point(s): Efficacy of S-ketamine in lowering postoperative analgesic consumption and prevent hyperalgesia.—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026